Registrat-Mapi
12
0
0
8
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 50/100
33.3%
4 terminated/withdrawn out of 12 trials
66.7%
-19.8% vs industry average
58%
7 trials in Phase 3/4
88%
7 of 8 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
A Prospective, Noninterventional Follow-Up Study of Children Aged 23 to 25 Months, Born to Mothers Who Received Hydroxyprogesterone Caproate Injection, 250 mg/mL, or Vehicle for Prevention of Preterm Birth
Role: collaborator
Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery
Role: collaborator
International Registry on the Quality of Life of Patients With Grass-pollen-induced Allergic Rhinitis
Role: collaborator
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
Role: collaborator
Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States
Role: collaborator
A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy
Role: collaborator
A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B504
Role: collaborator
A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301
Role: collaborator
A Health Economic Trial in Adult Patients Undergoing Ileostomy Reversal MA402S23B501
Role: collaborator
A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302
Role: collaborator
Adult Patients Undergoing Open Colectomy MA402S23B303
Role: collaborator
Treatment Decision Impact of OncotypeDX™ in HR+, N- Breast Cancer Patients
Role: collaborator
All 12 trials loaded